Search Results - "Sella, A."

Inflammatory Joint Diseases and Risk of Cardiovascular Disease in Modern Rheumatology by Berg, Inger Jorid, Provan, Sella A.

Get full text

Trends in all-cause and cardiovascular mortality in patients with incident rheumatoid arthritis: a 20-year follow-up matched case-cohort study by Provan, Sella A, Lillegraven, Siri, Sexton, Joe, Angel, Kristin, Austad, Cathrine, Haavardsholm, Espen A, Kvien, Tore K, Uhlig, Till

“…Abstract Objectives To examine all-cause and cardiovascular disease (CVD) mortality in consecutive cohorts of patients with incident RA, compared with…”
Get full text

Treating Fatigue in Rheumatoid Arthritis: Does Patient Age Matter? by Uhlig, Till, Provan, Sella A.

“…Clinically relevant fatigue is common in patients with rheumatoid arthritis (RA) and might be expected to be related to patient age and disease severity. This…”
Get full text

Swollen, but not tender joints, are independently associated with ultrasound synovitis: results from a longitudinal observational study of patients with established rheumatoid arthritis by Hammer, Hilde Berner, Michelsen, Brigitte, Sexton, Joseph, Haugen, Ida K, Provan, Sella A, Haavardsholm, Espen A, Uhlig, Till, Kvien, Tore K

“…Joint swelling and tenderness are considered a proxy for inflammation in patients with rheumatoid arthritis (RA). With ultrasound-detected inflammation as…”
Get more information

Definition of rheumatoid arthritis flare based on SDAI and CDAI by Konzett, Victoria, Kerschbaumer, Andreas, Smolen, Josef S, Kristianslund, Eirik Klami, Provan, Sella A, Kvien, Tore K, Aletaha, Daniel

“…To develop and validate definitions for disease flares in rheumatoid arthritis (RA) based on the quantitative Simplified and Clinical Disease Activity Indices…”
Get more information

Effect of 1-year anti-TNF-α therapy on aortic stiffness, carotid atherosclerosis, and calprotectin in inflammatory arthropathies: a controlled study by Angel, Kristin, Provan, Sella A., Fagerhol, Magne K., Mowinckel, Petter, Kvien, Tore K., Atar, Dan

“…Background Premature arterial stiffening and atherosclerosis are increased in patients with inflammatory arthropathies such as rheumatoid arthritis (RA),…”
Get full text

The changing states of fibromyalgia in patients with axial spondyloarthritis: results from the British Society of Rheumatology Biologics Register for Ankylosing Spondylitis by Provan, Sella A, Dean, Linda E, Jones, Gareth T, Macfarlane, Gary J

“…Abstract Objectives To identify factors associated with FM development and recovery in patients with axial SpA (axSpA). Methods The British Society of…”
Get full text

Carotid Plaque Characteristics and Disease Activity in Rheumatoid Arthritis by SEMB, Anne G, ROLLEFSTAD, Silvia, PROVAN, Sella A, KVIEN, Tore K, STRANDEN, Einar, OLSEN, Inge C, HISDAL, Jonny

“…Carotid plaques (CP) are predictive of acute coronary syndrome in patients with rheumatoid arthritis (RA), suggesting that atherosclerotic plaques in these…”
Get full text

Persisting mortality gap in systemic lupus erythematosus; a population-based study on juvenile- and adult-onset SLE in Norway 1999-2022 by Moe, Sigrid Reppe, Haukeland, Hilde, Brunborg, Cathrine, Botea, Antonela, Damjanic, Nenad, Wivestad, Gro Årthun, Øvreås, Heidi, Bøe, Thea, Orre, Anniken, Garen, Torhild, Lilleby, Vibke, Provan, Sella A, Molberg, Øyvind, Lerang, Karoline

“…To estimate mortality and survival rates of SLE in a contemporary, population-based setting and assess potential influences by time, sex, ethnicity,…”
Get full text

Predictive Value of Arterial Stiffness and Subclinical Carotid Atherosclerosis for Cardiovascular Disease in Patients with Rheumatoid Arthritis by Ikdahl, Eirik, Rollefstad, Silvia, Wibetoe, Grunde, Olsen, Inge C, Berg, Inger-Jorid, Hisdal, Jonny, Uhlig, Till, Haugeberg, Glenn, Kvien, Tore K, Provan, Sella A, Semb, Anne Grete

“…We evaluated the predictive value of these vascular biomarkers for cardiovascular disease (CVD) events in patients with rheumatoid arthritis (RA): aortic pulse…”
Get full text

Immunogenicity and Safety of Standard and Third‐Dose SARS–CoV‐2 Vaccination in Patients Receiving Immunosuppressive Therapy by Syversen, Silje W., Jyssum, Ingrid, Tveter, Anne T., Tran, Trung T., Sexton, Joseph, Provan, Sella A., Mjaaland, Siri, Warren, David J., Kvien, Tore K., Grødeland, Gunnveig, Nissen‐Meyer, Lise S. H., Ricanek, Petr, Chopra, Adity, Andersson, Ane M., Kro, Grete B., Jahnsen, Jørgen, Munthe, Ludvig A., Haavardsholm, Espen A., Vaage, John T., Lund‐Johansen, Fridtjof, Jørgensen, Kristin K., Goll, Guro L.

“…Objective Immunogenicity and safety following receipt of the standard SARS–CoV‐2 vaccination regimen in patients with immune‐mediated inflammatory diseases…”
Get full text

Developing and externally validating multinomial prediction models for methotrexate treatment outcomes in patients with rheumatoid arthritis: results from an international collaboration by Gehringer, Celina K., Martin, Glen P., Hyrich, Kimme L., Verstappen, Suzanne M.M., Sexton, Joseph, Kristianslund, Eirik K., Provan, Sella A., Kvien, Tore K., Sergeant, Jamie C.

“…In rheumatology, there is a clinical need to identify patients at high risk (>50%) of not responding to the first-line therapy methotrexate (MTX) due to lack…”
Get full text

Tender Joint Count and Inflammatory Activity in Patients With Established Rheumatoid Arthritis: Results From a Longitudinal Study by Hammer, Hilde B., Michelsen, Brigitte, Provan, Sella A., Sexton, Joe, Lampa, Jon, Uhlig, Tillmann, Kvien, Tore K.

“…Objective The tender joint count (TJC) is included in composite disease activity scores (CDAS) (the Disease Activity Score in 28 joints, the Clinical Disease…”
Get full text

Evidence of reduced parasympathetic autonomic regulation in inflammatory joint disease: A meta-analyses study by Provan, Sella A., Olstad, Daniela Schäfer, Solberg, Erik E., Smedslund, Geir, Dagfinrud, Hanne

“…Rheumatoid arthritis (RA) and spondyloarthritis (SpA) are inflammatory joint disorders (IJD) with increased risk of cardiovascular disease (CVD). Autonomic…”
Get full text

Serious infections in patients with rheumatoid arthritis and psoriatic arthritis treated with tumour necrosis factor inhibitors: data from register linkage of the NOR-DMARD study by Christensen, Ingrid Egeland, Lillegraven, Siri, Mielnik, Pawel, Bakland, Gunnstein, Loli, Liz, Sexton, Joe, Uhlig, Till, Kvien, Tore K, Provan, Sella A

“…To estimate the incidence of serious infections (SIs) in patients with rheumatoid arthritis (RA) and psoriatic arthritis (PsA) treated with tumour necrosis…”
Get more information

Dynamics of SARS-CoV-2 immunity after vaccination and breakthrough infection in rituximab-treated rheumatoid arthritis patients: a prospective cohort study by Kared, Hassen, Jyssum, Ingrid, Alirezaylavasani, Amin, Egner, Ingrid M, The Tran, Trung, Tietze, Lisa, Lund, Katrine Persgård, Tveter, Anne Therese, Provan, Sella A, Ørbo, Hilde, Haavardsholm, Espen A, Vaage, John Torgils, Jørgensen, Kristin, Syversen, Silje Watterdal, Lund-Johansen, Fridtjof, Goll, Guro Løvik, Munthe, Ludvig A

“…SARS-CoV-2 vaccination in rheumatoid arthritis (RA) patients treated with B cell-depleting drugs induced limited seroconversion but robust cellular response…”
Get full text

Short-term, intermediate-term and long-term risks of acute coronary syndrome in cohorts of patients with RA starting biologic DMARDs: results from four Nordic countries by Delcoigne, Benedicte, Ljung, Lotta, Provan, Sella A, Glintborg, Bente, Hetland, Merete Lund, Grøn, Kathrine Lederballe, Peltomaa, Ritva, Relas, Heikki, Turesson, Carl, Gudbjornsson, Bjorn, Michelsen, Brigitte, Askling, Johan

“…To compare the 1-year, 2-year and 5-year incidences of acute coronary syndrome (ACS) in patients with rheumatoid arthritis (RA) starting any of the biologic…”
Get more information

Fatigue is cross-sectionally not associated with objective assessments of inflammation, but changes in fatigue are associated with changes of disease activity assessments during biologic treatment of patients with established rheumatoid arthritis by Hammer, Hilde Berner, Michelsen, Brigitte, Sexton, Joe, Uhlig, Till, Provan, Sella A.

“…Objective The associations between fatigue and disease activity in patients with rheumatoid arthritis (RA) have not been defined. The present objectives were…”
Get full text

How does current disease activity in rheumatoid arthritis affect the short-term risk of acute coronary syndrome? A clinical register based study from Sweden and Norway by Delcoigne, Bénédicte, Provan, Sella A., Kristianslund, Eirik K, Askling, Johan, Ljung, Lotta

“…•The short-term cardiovascular risk increases with increasing disease activity in patients with rheumatoid arthritis.•Not being in remission is associated with…”
Get full text

Uptake and effectiveness of newer biologic and targeted synthetic disease-modifying antirheumatic drugs in psoriatic arthritis: results from five Nordic biologics registries by Glintborg, Bente, Di Giuseppe, Daniela, Wallman, Johan Karlsson, Nordström, Dan C, Gudbjornsson, Bjorn, Hetland, Merete Lund, Askling, Johan, Grondal, Gerdur, Sokka, Tuulikki, Provan, Sella A, Michelsen, Brigitte, Kristianslund, Eirik Klami, Dreyer, Lene, Love, Thorvardur Jon, Lindström, Ulf

“…We aimed to describe the uptake of newer biologic or targeted synthetic disease-modifying antirheumatic drugs (b/tsDMARDs) in psoriatic arthritis (PsA) in the…”
Get more information